Effect of primary tumor size in patients with metastatic non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Xia, Bing
Gao, Feng
Govindan, Ramaswamy
Morgensztern, Daniel
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Washington Univ, Sch Med St Louis, St Louis, MO USA
[3] Siteman Canc Ctr, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8041
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Radiogenomics in 332 metastatic non-small cell lung cancer (NSCLC) patients.
    Remon, Jordi
    Faivre, Laura
    Facchinetti, Francesco
    Bluthgen, Maria Virginia
    Pignon, Jean-Pierre
    Planchard, David
    Lacroix, Ludovic
    Besse, Benjamin
    Soria, Jean-Charles
    Caramella, Caroline
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.
    Yu, X.
    Gao, B.
    Ma, Z.
    Chu, Q.
    Huang, D.
    Zhao, J.
    Day, D.
    Body, A. L.
    Pan, H.
    Cui, J.
    Li, H.
    Sun, J.
    Zhang, J.
    Fei, C.
    Wu, Y-L.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S1 - S2
  • [3] Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.
    Yu, X.
    Gao, B.
    Ma, Z.
    Chu, Q.
    Huang, D.
    Zhao, J.
    Day, D.
    Body, A. L.
    Pan, H.
    Cui, J.
    Chen, C.
    Xiang, X.
    Fei, C.
    Yang, L.
    Wu, Y-L.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S996 - S997
  • [4] Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC)
    Wei, Jia
    Moran, Teresa
    Zou, Zhengyun
    Qian, Xiaoping
    Wang, Lifeng
    Camps, Carlos
    Hu, Wenjing
    Chaib, Imane
    Sanchez, Belen
    Xu, Lixia
    Karachaliou, Niki
    Sanchez-Ronco, Maria
    Liu, Baorui
    Rosell, Rafael
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2013, 2 (03) : 180 - 188
  • [5] THE IMPORTANCE OF MONOTOTAL FOR PRIMARY DIAGNOSIS OF PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Topolcan, O.
    Holubec, L.
    Safranek, J.
    Prazakova, M.
    Vrzalova, J.
    Casova, M.
    Svobodova, S.
    Dresslerova, J.
    Treska, Vladislav
    Pesek, M.
    Finek, J.
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4038 - 4039
  • [6] Non-small cell lung cancer (NSCLC) in elderly patients
    Batura-Gabryel, H.
    Brajer, B.
    [J]. LUNG CANCER, 2006, 52 : S19 - S19
  • [7] Comorbidity in clinical trial patients with advanced or metastatic non-small cell lung cancer (NSCLC).
    Kosov, Maxim
    Kumar, Akhil
    Belotserkovskiy, Maxim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Screening for mutations in Colombian metastatic non-small cell lung cancer (NSCLC) patients (ONCOLGroup).
    Cardona, A. F.
    Ramos, P. L.
    Duarte, R.
    Carranza, H.
    Castro, C. J.
    Lema, M.
    Vargas, C. A.
    Jimenez, A.
    Becerra, H. A.
    Rosell, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] The Checkpoint Inhibitors for the Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)
    Hirsh, Vera
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [10] Effect of Statins and Metformin on Survival in Patients With Non-small Cell Lung Cancer (NSCLC)
    Duma, Narjust
    Kang, Mohleen
    Abu-Ihweij, Khaleb
    Moaz, Choudhary
    DosSantos, Maira
    Gandhi, Arpita
    Gutierrez, Martin
    [J]. CHEST, 2015, 148 (04)
12345